Results showed that CD19+ cells expressing IFNγ were significantly increased in patients with a diagnosis of PP multiple sclerosis compared to SP, RR, BEMS individuals and HC (p < 0.005)(Fig. 2E,F). This evidence concerns the gene CD19 and multiple sclerosis.